These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23957541)

  • 1. Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis.
    Ribeiro S; Ferreira B; Duarte R; Almeida I; Vasconcelos C
    Scand J Infect Dis; 2013 Dec; 45(12):957-60. PubMed ID: 23957541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.
    Denis B; Lefort A; Flipo RM; Tubach F; Lemann M; Ravaud P; Salmon D; Mariette X; Lortholary O;
    Clin Microbiol Infect; 2008 Feb; 14(2):183-6. PubMed ID: 18076664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
    Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
    Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for rheumatoid arthritis in a patient with tuberculosis.
    Matsumoto T; Tanaka T; Kawase I
    N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated tuberculosis secondary to adalimumab.
    Pednekar M; Chandra AB; Chandra PA
    Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments.
    Bieber J; Kavanaugh A
    Rheum Dis Clin North Am; 2004 May; 30(2):257-70, v. PubMed ID: 15172039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
    Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
    Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
    Winthrop KL
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):602-10. PubMed ID: 17075599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.
    Franklin G; Greenspan J; Chen S
    Ann Clin Lab Sci; 2009; 39(2):192-5. PubMed ID: 19429808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.
    Stokes MB; Foster K; Markowitz GS; Ebrahimi F; Hines W; Kaufman D; Moore B; Wolde D; D'Agati VD
    Nephrol Dial Transplant; 2005 Jul; 20(7):1400-6. PubMed ID: 15840673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active tuberculosis in a patient with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitor.
    Fuchs I; Abu-Shakra M; Gelfer E; Smoliakov A; Ben-Haroch D; Horowitz J; Avnon LS
    Isr Med Assoc J; 2010 Sep; 12(9):579-81. PubMed ID: 21287806
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.
    To KW; Reino JJ; Yoo DH; Tam LS
    Respirology; 2013 Jul; 18(5):765-73. PubMed ID: 23627398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of rheumatoid arthritis presenting with pulmonary tuberculosis].
    Katoh K; Taniguchi H; Okouchi A; Kudo M; Kawai T
    Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):782-6. PubMed ID: 15455955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.
    Efde MN; Houtman PM; Spoorenberg JP; Jansen TL
    Neth J Med; 2005 Mar; 63(3):112-4. PubMed ID: 15813424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubercular pyomyositis in a case of rheumatoid arthritis being treated with infliximab.
    Khosla P; Aroaa N; Jain S
    Int J Rheum Dis; 2010 Feb; 13(1):82-5. PubMed ID: 20374389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tuberculosis by extensive screening in a patient with rheumatoid arthritis prior to anti-TNF-alpha therapy.
    Iseli A; Hüllstrung HD; Rodenhausen S; Widmer AF; Tyndall A; Hasler P
    Rheumatology (Oxford); 2006 Aug; 45(8):1049-50. PubMed ID: 16769772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
    Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
    Reumatizam; 2007; 54(1):16-9. PubMed ID: 18450272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset tuberculosis infection in patients receiving anti-TNFα therapy.
    Mongey AB; Doran JP; Kleinerova J; Fitzgerald O; McDonnell TJ
    QJM; 2014 Jan; 107(1):69-71. PubMed ID: 23970181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
    Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
    Reumatizam; 2008; 55(1):22-5. PubMed ID: 19024266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.